The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer

Journal of Ovarian Research

Volumn 7, Issue 1, 2014, Pages

  Takai, Masaaki ^a   Terai, Yoshito ^a   Kawaguchi, Hiroshi ^a   Ashihara, Keisuke ^a   Fujiwara, Satoe ^a   Tanaka, Tomohito ^a   Tsunetoh, Satoshi ^a   Tanaka, Yoshimichi ^a   Sasaki, Hiroshi ^a   Kanemura, Masanori ^a   Tanabe, Akiko ^a   Ohmichi, Masahide ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

E cadherin; EMT; Epithelial mesenchymal transition; Ovarian cancer; Snail

Indexed keywords

TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; CADHERIN; PROTEOME; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER TISSUE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENDOMETRIOID CARCINOMA; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARIECTOMY; OVARY ADENOCARCINOMA; OVARY CARCINOMA; OVARY CLEAR CELL CARCINOMA; OVERALL SURVIVAL; PERITONEUM METASTASIS; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TISSUE SECTION; AGED; CANCER STAGING; ENDOMETRIUM TUMOR; GENE EXPRESSION; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; OVARY TUMOR; PATHOLOGY; PROGNOSIS; TUMOR RECURRENCE;

ADULT; AGED; CADHERINS; ENDOMETRIAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; PROTEOME; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84904784607     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-7-76     Document Type: Article

References (39)

1. Treatment goals in ovarian cancer. Ozolos RF, Int J Gynecol Cancer 2005 15 3 11 10.1111/j.1525-1438.2005.15351.x 15839952
2. Complex networks orchestrate epithelial-mesenchymal transitions. Thiery JP, Sleeman JP, Nat Rev Mol Cell Biol 2006 7 131 142 10.1038/nrm1835 16493418
3. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW, J Cell Physiol 2007 213 374 383 10.1002/jcp.21223 17680632
4. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Yang J, Weinberg RA, Dev Cell 2008 14 818 829 10.1016/j.devcel.2008.05.009 18539112
5. Transitions between epithelial and mesenchymal states in development and disease. Baum B, Settleman J, Quinlan MP, Semin Cell Dev Biol 2008 19 294 308 10.1016/j.semcdb.2008.02.001 18343170
6. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Grunert S, Jechlinger M, Beug H, Nat Rev Mol Cell Biol 2003 4 657 665 10.1038/nrm1175 12923528
7. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Huber MA, Kraut N, Beug H, Curr Opin Cell Biol 2005 17 548 558 10.1016/j.ceb.2005.08.001 16098727
8. The snail superfamily of zinc-finger transcription factors. Nieto MA, Nat Rev Mol Cell Biol 2002 3 155 166 10.1038/nrm757 11994736
9. Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Hemavathy K, Ashraf SI, Ip YT, Gene 2000 257 1 12 10.1016/S0378-1119(00)00371-1 11054563
10. Mutations and chromosomal rearrangements affecting the expression of snail, a gene involved in embryonic patterning in DROSOPHILA MELANOGASTER. Grau Y, Carteret C, Simpson P, Genetics 1984 108 347 360 17246230
11. The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes. Valdes F, Alvarez AM, Locascio A, Vega S, Herrera B, Fernandez M, Benito M, Nieto MA, Fabregat I, Mol Cancer Res 2002 1 68 78 12496370
12. The radioresistance biological function of the SCF/kit signaling pathway is mediated by the zinc-finger transcription factor Slug. Perez-Losada J, Sanchez-Martin M, Perez-Caro M, Perez-Mancera PA, Sanchez-Garcia I, Oncogene 2003 22 4205 4211 10.1038/sj.onc.1206467 12833143
13. Snail blocks the cell cycle and confers resistance to cell death. Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I, Nieto MA, Genes Dev 2004 18 1131 1143 10.1101/gad.294104 15155580
14. Cadherins in cancer: implications for invasion and metastasis. Takeichi M, Curr Opin Cell Biol 1993 5 806 811 10.1016/0955-0674(93)90029-P 8240824
15. E-cadherin-catenin cell-cell adhesion complex and human cancer. Wijnhoven BP, Dinjens WN, Pignatelli M, Br J Surg 2000 87 992 1005 10.1046/j.1365-2168.2000.01513.x 10931041
16. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. Sakuragi N, Nishiya M, Ikeda K, Ohkouch T, Furth EE, Hareyama H, Satoh C, Fujimoto S, Gynecol Oncol 1994 53 183 189 10.1006/gyno.1994.1113 8188077
17. Expression of E-cadherin in primary and metastatic prostate cancer. Cheng L, Nagabhushan M, Pretlow TP, Amini SB, Pretlow TG, Am J Pathol 1996 148 1375 1380 8623909
18. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. Bremnes RM, Veve R, Gabrielson E, Hirsch FR, Baron A, Bemis L, Gemmill RM, Drabkin HA, Franklin WA, J Clin Oncol 2002 20 2417 2428 10.1200/JCO.2002.08.159 12011119
19. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, Baylin SB, Cancer Res 1995 55 5195 5199 7585573
20. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S, Proc Natl Acad Sci U S A 1995 92 7416 7419 10.1073/pnas.92.16.7416 7543680
21. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Grooteclaes ML, Frisch SM, Oncogene 2000 19 3823 3828 10.1038/sj.onc.1203721 10949939
22. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Comijn J, Berx G, Vermassen P, Verschueren K, Van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, Van Roy F, Mol Cell 2001 7 1267 1278 10.1016/S1097-2765(01)00260-X 11430829
23. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J, Nieto MA, Oncogene 2002 21 3241 3246 10.1038/sj.onc.1205416 12082640
24. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, Van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L, Cancer Res 2003 63 2172 2178 12727836
25. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Hajra KM, Chen DY, Fearon ER, Cancer Res 2002 62 1613 1618 11912130
26. Transcriptional repressor snail and progression of human hepatocellular carcinoma. Sugimachi K, Tanaka S, Kameyama T, Taguchi K, Aishima S, Shimada M, Sugimachi K, Tsuneyoshi M, Clin Cancer Res 2003 9 2657 2664 12855644
27. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A, Nat Cell Biol 2000 2 84 89 10.1038/35000034 10655587
28. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, Del Barrio MG, Portillo F, Nieto MA, Nat Cell Biol 2000 2 76 83 10.1038/35000025 10655586
29. The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. Blechschmidt K, Sassen S, Schmalfeldt B, Schuster T, Hofler H, Becker KF, Br J Cancer 2008 98 489 495 10.1038/sj.bjc.6604115 18026186
30. Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression. Tuhkanen H, Soini Y, Kosma VM, Anttila M, Sironen R, Hamalainen K, Mannermaa A, BMC Cancer 2009 9 289 10.1186/1471-2407-9-289 19695091
31. Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level. Kurrey NK, K A, Bapat SA, Gynecol Oncol 2005 97 155 165 10.1016/j.ygyno.2004.12.043 15790452
32. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Elloul S, Elstrand MB, Nesland JM, Trope CG, Kvalheim G, Goldberg I, Reich R, Davidson B, Cancer 2005 103 1631 1643 10.1002/cncr.20946 15742334
33. Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer. Tanaka Y, Terai Y, Kawaguchi H, Fujiwara S, Yoo S, Tsunetoh S, Takai M, Kanemura M, Tanabe A, Ohmichi M, Cancer Biol Ther 2013 14 13 19 10.4161/cbt.22625 23114646
34. Distinct mechanisms of tumor invasion and metastasis. Yilmaz M, Christofori G, Lehembre F, Trends Mol Med 2007 13 535 541 10.1016/j.molmed.2007.10.004 17981506
35. Elevated expression of E-cadherin and alpha-, beta-, and gamma-catenins in metastatic lesions compared with primary epithelial ovarian carcinoma. Imai T, Horiuchi A, Shiozawa T, Osada R, Kikuchi N, Ohira S, Oka K, Konishi I, Hum Pathol 2004 35 1469 1476 10.1016/j.humpath.2004.09.014 15619205
36. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer. Voutilainen KA, Anttila MA, Sillanpaa SM, Ropponen KM, Saarikoski SV, Juhola MT, Kosma NM, J Clin Pathol 2006 59 460 467 10.1136/jcp.2005.029876 16461565
37. Epithelial-mesenchymal transitions in development and disease. Thiery JP, Acloque H, Huang RY, Nieto MA, Cell 2009 139 871 890 10.1016/j.cell.2009.11.007 19945376
38. Epithelial-mesenchymal trasition in cancer development and its clinical significance. Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, Baba H, Mori M, Cancer Sci 2010 101 293 299 10.1111/j.1349-7006.2009.01419.x 19961486
39. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transistion in colorectal cancer cell lines. Yang AD, Fan F, Camp ER, Van Buren G, Liu W, Somcio R, Gray MJ, Cheng H, Hoff PM, Ellis LM, Clin Cancer Res 2006 12 4147 4153 10.1158/1078-0432.CCR-06-0038 16857785